Dr. Wahul Umesh B
"an indian scenario: emerging advances in nanotechnology as drug delivery system in rheumatoid arthritis".
Journal title : International Journal of Scientific Research in Biological Sciences
Publisher : ISROSET: International Scientific Research Organization for Science, Engineering and Technology
Online ISSN : 2347-7520
Page Number : 28-32
Journal volume : 5
Journal issue : 1
208 Views Original Article
There are several significant assays including bioavailability, Toxicity, high clearance, and further current therapies require higher and frequent dosing to gain desired therapeutic effects for Rheumatoid arthritis (RA). Nanoparticles have beenwidely investigated for rheumatoid arthritis (RA). Though, higher doses of Nanocarriers also increase the incidence of dreadful adverse effects. Wherever, nanocarrier properties are most populated by the use of different approaches like targeting ligands, to change the physicochemical properties including higher encapsulation, better penetrating ability in cells etc. The main advantage of the nanocarrier that they provide longer circulation which enhances drug localization at the inflamed site and selective targeting to enhance the therapeutic index of anti-arthritic drugs. However, the optimal properties of nanocarrier also depend on the route of administration and size of particles, thus larger size show more retention upon local injection and smaller sized ones are more optimal for passive targeting. The present article discusses the emergence of nano-carriers for antirheumatic drugs, which delivers drug molecule to the inflamed site by topical, intra-articular (i.a) and intra-venous (i.v) administration to take advantage of therapeutic efficacy by passive and active drug delivery. Advancements have been made extensively but still better investigations are needed to achieve the risk-benefit ratio for the development of safe, stable and effective targeting nanocarriers for the e treatment of rheumatoid arthritis (RA).
Article DOI & Crossmark Data
DOI : https://doi.org/10.26438/ijsrbs/v5i1.2832
Article Subject Details
- Arthritis
- Biotechnology
- Osteoarthritis
- Osteoarthritis of knee
- Pharmaceutical biotechnology
- Spondyloarthropathies
Article Keywords Details
Article File
Full Text PDFMore Article by Dr. Wahul Umesh B
“phyllanthus emblica” known to be amla has role in the skin aging influences the changes in skin, including skin dryness, wrinkle, and irregular pigmentation. initially the 6 day o...
The screening of perfect diuretics for non-clinical utility in diabetes mellitus is a relatively novel approach which gain inssight into underlying the pathophysiological processes...
The study of diabetes is not only limited to particular symptoms, but it is consequently affects the pathological and functional changes in the metabolic pathways of human body sys...
As we aware diabetes is not only one kind of symptomatic disease but its occurrence spread through the various metabolic channels and hence raises other disorders. the prolonged sy...